These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 30623363)
1. Targeting Colon Cancers with Mutated BRAF and Microsatellite Instability. Matos P; Jordan P Adv Exp Med Biol; 2018; 1110():7-21. PubMed ID: 30623363 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers. de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292 [TBL] [Abstract][Full Text] [Related]
3. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. Minoo P; Moyer MP; Jass JR J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169 [TBL] [Abstract][Full Text] [Related]
5. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer. Lin CC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Jiang JK; Yang MH; Chang SC J Surg Oncol; 2014 Sep; 110(4):451-7. PubMed ID: 24964758 [TBL] [Abstract][Full Text] [Related]
6. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer. Chouhan H; Sammour T; Thomas ML; Moore JW J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer. Chouhan H; Sammour T; L Thomas M; W Moore J Asia Pac J Clin Oncol; 2019 Feb; 15(1):69-74. PubMed ID: 30421554 [TBL] [Abstract][Full Text] [Related]
8. BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment? Cohen R; Cervera P; Svrcek M; Pellat A; Dreyer C; de Gramont A; André T Curr Treat Options Oncol; 2017 Feb; 18(2):9. PubMed ID: 28214977 [TBL] [Abstract][Full Text] [Related]
9. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504 [TBL] [Abstract][Full Text] [Related]
10. New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer. Cohen R; Svrcek M; Dreyer C; Cervera P; Duval A; Pocard M; Fléjou JF; de Gramont A; André T Curr Oncol Rep; 2016 Mar; 18(3):18. PubMed ID: 26861657 [TBL] [Abstract][Full Text] [Related]
12. Targeting the serrated pathway of colorectal cancer with mutation in BRAF. Matos P; Gonçalves V; Jordan P Biochim Biophys Acta; 2016 Aug; 1866(1):51-63. PubMed ID: 27345584 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of BRAF V600E Mutations in High-Level Microsatellite Instability(MSI-H)Colon Cancer - Comparison Between Genetic Testing and Immunohistochemical Staining]. Sakimoto T; Chika N; Suzuki O; Ishibashi K; Tachikawa T; Akagi K; Eguchi H; Okazaki Y; Ishida H Gan To Kagaku Ryoho; 2016 Nov; 43(12):1693-1695. PubMed ID: 28133101 [TBL] [Abstract][Full Text] [Related]
15. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. Samowitz WS; Albertsen H; Sweeney C; Herrick J; Caan BJ; Anderson KE; Wolff RK; Slattery ML J Natl Cancer Inst; 2006 Dec; 98(23):1731-8. PubMed ID: 17148775 [TBL] [Abstract][Full Text] [Related]
16. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions. Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407 [TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer. Birgisson H; Edlund K; Wallin U; Påhlman L; Kultima HG; Mayrhofer M; Micke P; Isaksson A; Botling J; Glimelius B; Sundström M BMC Cancer; 2015 Mar; 15():125. PubMed ID: 25884297 [TBL] [Abstract][Full Text] [Related]
18. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study. Wish TA; Hyde AJ; Parfrey PS; Green JS; Younghusband HB; Simms MI; Fontaine DG; Dicks EL; Stuckless SN; Gallinger S; McLaughlin JR; Woods MO; Green RC Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1831-9. PubMed ID: 20570909 [TBL] [Abstract][Full Text] [Related]